NASDAQ: RPRX · Health Care / Biotechnology: Pharmaceutical Preparations

Royalty Pharma plc

How Royalty Pharma plc compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$37.9B

Price

$65.93

P/E

45.1

EPS (TTM)

$1.46

1-year return

78.5%

Dividend yield

0.0%

52-week range

$37.30–$65.93

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources